FibroSIGHT™ Plus: Precision in Fibrosis Assessment with AI-based Analysis

Newsletters

Newsletter (February 2026)

February Highlights qFibrosis® Uncovers Divergent Collagen Remodeling Across Liver Disease Subtypes A recent study conducted by Seoul National University Boramae Medical Center and Kyung Hee University Hospital provides new insights into fibrosis progression across steatotic liver disease subtypes. Now published in Gastroenterology, the study utilized HistoIndex’s fibrosis quantification algorithm, qFibrosis®, to identify distinct patterns of […]

Newsletter (February 2026) Read More »

Newsletter (January 2026)

Advancing MASH Diagnostics Through Strategic Partnerships January 20, 2026 – HistoIndex is set to expand its footprint in clinical hepatology and gastroenterology through new commercial partnerships with leading medical centers in the US and Europe. These collaborations unlock our unique diagnostic offering, which combines standard histopathological evaluation by expert pathologists with AI-driven biopsy analysis. Such

Newsletter (January 2026) Read More »